الابحاث

South Egypt Cancer Institute

Assiut University

Department of Medical Oncology
# Title Research Member Research Year
11 FOXP3 Expression as a Biomarker in Metastatic Colorectal Cancer Treated with Irinotecan-based Therapy Dr. Salah Mabrouk Khallaf Abd Rabou 2023
12 Tumor Lymphocytic Infiltration as a Prognostic Factor in Gastric Carcinoma Dr. Marwa Tammam Ameen Hammam 2023
13 FOXP3 Expression as a Biomarker in Metastatic Colorectal Cancer Treated with Irinotecan-based Therapy Dr. Shimaa Hassan Shabaan Hassan 2023
14 Tumor Lymphocytic Infiltration as a Prognostic Factor in Gastric Carcinoma Sanaa Saber Abdelraheem Barakat 2023
15 FOXP3 Expression as a Biomarker in Metastatic Colorectal Cancer Treated with Irinotecan-based Therapy Dr. Amen Hamdy Zaki Ali 2023
16 CD44 as a prognostic marker in early colorectal cancer: single center experience “South Egypt cancer institute”, Egypt Amany Nasr Ahmed Mohammed Elemary 2023
17 Ewing sarcoma outcomes in a country with limited resources: Egypt as an example Dr. Ahmed Mubarak Hefni Ismail 2021
18 Role of Metastatic Colon Cancer Topography in Pathological and Molecular Variability : A Retrospective Study Dr. Adel Gomaa Mohamed Gabr 2021
19 Interleukin-10: A Potential Prognostic Marker in Patients with Newly Diagnosed Multiple Myeloma Dr. Salah Mabrouk Khallaf Abd Rabou 2021
20 Ewing sarcoma outcomes in a country with limited resources: Egypt as an example Mahmoud Gamal Ameen 2021